Abstract
Purpose
The aim of this study was to investigate an imaging biomarker based on contrast enhanced T1-weighted and T2-weighted magnetic resonance imaging (MRI) to determine the hearing loss related to acoustic neuromas (AN).
Methods
In this retrospective study, 441 acoustic neuromas treated with microsurgery were included. The diagnostic and follow-up MRI and audiometry of these patients were compared.
Results
We discovered a new MRI grading biomarker based on the percentage of tumor filling the inner auditory canal (TFIAC classification). The area under the receiver operating characteristics (AUROC) curve was highest for TFIAC (0.675), followed by period of observation (0.615) and tumor size (0.6) (P < 0.001). The percentage of patients in TFIAC grade III (90.1%) experiencing hypoacusis prior to microsurgery was significantly higher than that in TFIAC grade I (72.7%, P = 0.037) and TFIAC grade IV patients had a higher rate of non-serviceable hearing compared to TFIAC grade III patients (P < 0.001). During the follow-up, TFIAC grade IV patients experienced a significantly higher rate of non-serviceable hearing than TFIAC grade III patients in all ANs (P < 0.001) and in serviceable hearing acoustic neuroma cases prior to surgery (TFIAC grade IV 55.4%, TFIAC grade III 69.0%, P = 0.045). The TFIAC grade IV patients experienced a significantly higher rate of facial nerve dysfunction than TFIAC grade III patients after surgery (grade IV 48.0%, grade III 26.1%, P < 0.001).
Conclusion
The TFIAC classification serves as a potential imaging biomarker for preoperative and postoperative hearing prediction in ANs, which may aid neurosurgeons in predicting hearing loss and selecting optimal surgical strategies.
Similar content being viewed by others
Abbreviations
- AAO-HNS:
-
American Academy of Otolaryngology-Head and Neck Surgery
- ABR:
-
Auditory brainstem response
- AN:
-
Acoustic neuromas
- AUROC:
-
Area under the receiver operating characteristics
- GR:
-
Gardner-Robertson
- H‑B:
-
House-Brackmann
- IAC:
-
Inner auditory canal
- MRI:
-
Magnetic resonance imaging
- ROC:
-
Receiver operating characteristics
- RT:
-
Radiation therapy
- SDS:
-
Speech discrimination score
- SRT:
-
Speech repetition threshold
- TFIAC:
-
Tumor filling inner auditory canal
- VS:
-
Vestibular schwannomas
References
Lin D, Hegarty JL, Fischbein NJ, Jackler RK. The prevalence of “incidental” acoustic neuroma. Arch Otolaryngol Head Neck Surg. 2005;131:241–4.
Whitmore RG, Urban C, Church E, Ruckenstein M, Stein SC, Lee JY. Decision analysis of treatment options for vestibular schwannoma. J Neurosurg. 2011;114:400–13.
Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD. The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation? Neurosurg Focus. 2012;33:E8.
Zanoletti E, Cazzador D, Faccioli C, Gallo S, Denaro L, D’Avella D, et al. Multi-option therapy vs observation for small acoustic neuroma: hearing-focused management. Acta Otorhinolaryngol Ital. 2018;38:384–92.
Pollock BE, Lunsford LD, Norén G. Vestibular schwannoma management in the next century: a radiosurgical perspective. Neurosurgery. 1998;43:475–81; discussion 481–3.
Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD, et al. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery. 2006;59:77–85; discussion 77–85.
Ammoun S, Hanemann CO. Emerging therapeutic targets in schwannomas and other merlin-deficient tumors. Nat Rev Neurol. 2011;7:392–9.
Masuda A, Fisher LM, Oppenheimer ML, Iqbal Z, Slattery WH, Natural History Consortium. Hearing changes after diagnosis in neurofibromatosis type 2. Otol Neurotol. 2004;25:150–4.
Santa Maria PL, Shi Y, Gurgel RK, Corrales CE, Soltys SG, Santa Maria C, et al. Long-term hearing outcomes following stereotactic radiosurgery in vestibular schwannoma patients—A retrospective cohort study. Neurosurgery. 2019;85:550–9.
Frischer JM, Gruber E, Schöffmann V, Ertl A, Höftberger R, Mallouhi A, et al. Long-term outcome after Gamma Knife radiosurgery for acoustic neuroma of all Koos grades: a single-center study. J Neurosurg. 2019;130:388–97.
Golfinos JG, Hill TC, Rokosh R, Choudhry O, Shinseki M, Mansouri A, et al. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas. J Neurosurg. 2016;125:1472–82.
Yamakami I, Ito S, Higuchi Y. Retrosigmoid removal of small acoustic neuroma: curative tumor removal with preservation of function. J Neurosurg. 2014;121:554–63.
Wind JJ, Leonetti JP, Raffin MJ, Pisansky MT, Herr B, Triemstra JD, et al. Hearing preservation in the resection of vestibular schwannomas: patterns of hearing preservation and patient-assessed hearing function. J Neurosurg. 2011;114:1232–40.
Tanrikulu L, Lohse P, Fahlbusch R, Naraghi R. Hearing preservation in acoustic neuroma resection: Analysis of petrous bone measurement and intraoperative application. Surg Neurol Int. 2016;7(Suppl 40):S980–8.
Rezaii E, Li D, Heiferman DM, Szujewski CC, Martin B, Cobb A, et al. Effect of institutional volume on acoustic neuroma surgical outcomes: State Inpatient Database 2009–2013. World Neurosurg. 2019;129:e754–60.
Nelson RF, Hansen MR, Gantz BJ. Hearing preservation surgery for vestibular schwannomas. Curr Otorhinolaryngol Rep. 2014;2:235–41.
Nakatomi H, Miyazaki H, Tanaka M, Kin T, Yoshino M, Oyama H, et al. Improved preservation of function during acoustic neuroma surgery. J Neurosurg. 2015;122:24–33.
Monsell EM. New and revised reporting guidelines from the Committee on Hearing and Equilibrium. Otolaryngol Head Neck Surg. 1995;113:176–8.
Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol. 1988;97:55–66.
Kirchmann M, Karnov K, Hansen S, Dethloff T, Stangerup SE, Caye-Thomasen P. Ten-year follow-up on tumor growth and hearing in patients observed with an intracanalicular vestibular schwannoma. Neurosurgery. 2017;80:49–56.
Croxson G, May M, Mester SJ. Grading facial nerve function: House-Brackmann versus Burres-Fisch methods. Am J Otol. 1990;11:240–6.
Lewis BI, Adour KK. An analysis of the Adour-Swanson and House-Brackmann grading systems for facial nerve recovery. Eur Arch Otorhinolaryngol. 1995;252:265–9.
Engstrom M, Jonsson L, Grindlund M, Stalberg E. House-Brackmann and Yanagihara grading scores in relation to electroneurographic results in the time course of Bell’s palsy. Acta Otolaryngol. 1998;118:783–9.
Erickson NJ, Schmalz PGR, Agee BS, Fort M, Walters BC, McGrew BM, et al. Koos classification of vestibular schwannomas: a reliability study. Neurosurgery. 2019;85:409–14.
Di Maio S, Malebranche AD, Westerberg B, Akagami R. Hearing preservation after microsurgical resection of large vestibular schwannomas. Neurosurgery. 2011;68:632–40; discussion 640.
Stummer W, Reulen HJ, Meinel T, Pichlmeier U, Schumacher W, Tonn JC, et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62:564–76; discussion 564–76.
Zanoletti E, Mazzoni A, d’Avella D. Hearing preservation in small acoustic neuroma: observation or active therapy? Literature review and institutional experience. Acta Neurochir (Wien). 2019;161:79–83.
Tolisano AM, Hunter JB. Hearing preservation in stereotactic radiosurgery for vestibular schwannoma. J Neurol Surg B Skull Base. 2019;80:156–64.
Ochal-Choińska A, Lachowska M, Kurczak K, Niemczyk K. Audiologic prognostic factors for hearing preservation following vestibular schwannoma surgery. Adv Clin Exp Med. 2019;28:747–57.
Carlson ML, Link MJ, Wanna GB, Driscoll CL. Management of sporadic vestibular schwannoma. Otolaryngol Clin North Am. 2015;48:407–22.
Yong RL, Westerberg BD, Dong C, Akagami R. Length of tumor-cochlear nerve contact and hearing outcome after surgery for vestibular schwannoma. J Neurosurg. 2008;108:105–10.
Farid N. Imaging of vestibular schwannoma and other cerebellopontine angle tumors. Oper Tech Otolaryngol Neck Surg. 2014;25:87–95.
Kocaoglu M, Bulakbasi N, Ucoz T, Ustunsoz B, Pabuscu Y, Tayfun C, et al. Comparison of contrast-enhanced T1-weighted and 3D constructive interference in steady state images for predicting outcome after hearing-preservation surgery for vestibular schwannoma. Neuroradiology. 2003;45:476–81.
Rompaey VV, Dinther Jv, Zarowski A, Offeciers E, Somers T. Fundus obliteration and facial nerve outcome in vestibular schwannoma surgery. Skull Base. 2011;21:99–102.
Goddard JC, Schwartz MS, Friedman RA. Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma. Otol Neurotol. 2010;31:1128–34.
Lin EP, Crane BT. The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol. 2017;38:2034–43.
Mohr G, Sade B, Dufour JJ, Rappaport JM. Preservation of hearing in patients undergoing microsurgery for vestibular schwannoma: degree of meatal filling. J Neurosurg. 2005;102:1–5.
Stangerup SE, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma. Otol Neurotol. 2006;27:547–52.
Godefroy WP, Kaptein AA, Vogel JJ, van der Mey AG. Conservative treatment of vestibular schwannoma: a follow-up study on clinical and quality-of-life outcome. Otol Neurotol. 2009;30:968–74.
Fayad JN, Semaan MT, Lin J, Berliner KI, Brackmann DE. Conservative management of vestibular schwannoma: expectations based on the length of the observation period. Otol Neurotol. 2014;35:1258–65.
Dunn IF, Bi WL, Erkmen K, Kadri PA, Hasan D, Tang CT, et al. Medial acoustic neuromas: clinical and surgical implications. J Neurosurg. 2014;120:1095–104.
Dos Santos Neto PH, Zamponi JO, Hamerschmidt R, Wiemes GRM, Rassi MS, Borba LAB. Simultaneous cochlear implantation as a therapeutic option in vestibular schwannoma surgery: case report. Neurosurg Focus. 2018;44:E9.
Plontke SK, Kösling S, Rahne T. Cochlear implantation after partial or subtotal cochleoectomy for intracochlear schwannoma removal—A technical report. Otol Neurotol. 2018;39:365–71.
Funding
This work was financially supported by the Beijing Municipal Health Commission of China (Grant No. PXM2019_026280_000002, Recipient: Wang Jia).
Author information
Authors and Affiliations
Contributions
W.Z., Y.W., W.J. designed and performed experiments; W.Z., Y.W., S.M., L.Y. analyzed data and wrote the paper; X.W., D.Z., J.P., X.G. collected data from the Ddatabase system of Beijing Tiantan Hospital; G.J., W.J. performed the surgery; D.L. and W.J. provided statistical analysis and critical revision.
Corresponding author
Ethics declarations
Conflict of interest
W. Zhou, Y. Wang, S. Ma, L. Yuan, X. Wang, J. Peng,D. Zhang, X. Guan, D. Li, G. Jia and W. Jia declare that they have no competing interests.
Ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of Beijing Tiantan Hospital Research Committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Additional information
Availability of data and material
The data and materials that support the findings of this study are available from the corresponding author on reasonable request.
Rights and permissions
About this article
Cite this article
Zhou, W., Wang, Y., Ma, S. et al. A Novel Imaging Grading Biomarker for Predicting Hearing Loss in Acoustic Neuromas. Clin Neuroradiol 31, 599–610 (2021). https://doi.org/10.1007/s00062-020-00938-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-020-00938-7